Company intelligence / Profile preview

RMI Partners

Moscow, Russia

Ownership: Private
Development stage: Other

Overview

RMI Partners (RusnanoMedInvest) is a venture capital firm specializing in breakthrough developments in pharmaceuticals, biotechnology, and medical technology, with a focus on innovative projects in Russia, Eastern Europe, and the United States. It was established as a joint venture between Russia’s RUSNANO and the US-based Domain Associates, with the aim of creating world-class expertise in life sciences venture investment. RMI manages a ten-year, closed-end fund with about $200 million under management and has made 17 investments in biopharma and medtech companies.

Industry: Investors

Partnerships

Domain AssociatesRUSNANO

Beyond the preview

Go deeper on RMI Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RMI Partners.

Explore the full profile